In the present study, TriL treatment showed a dose-dependent inhibitory effect on carotid artery ligation-induced intimal hyperplasia and reduced PCNA expression in the neointima, which implies TriL may have therapeutic potential for cerebrovascular diseases. Here, PCNA is linked to cerebrovascular disorder.